TENAX THERAPEUTICS, INC. Amortization of Debt Discount (Premium)
TENAX THERAPEUTICS, INC. (TENX) reported Amortization of Debt Discount (Premium) of $16.68 thousand for the 12-month period ending 2015-04-30, per its 10-K filed 2017-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2017-03-16
- TENAX THERAPEUTICS, INC. amortization of debt discount (premium) for the quarter ending 2013-01-31 was $408.00K, a 0.00% change year-over-year.
- TENAX THERAPEUTICS, INC. amortization of debt discount (premium) for the quarter ending 2012-10-31 was $408.00K, a 0.00% change year-over-year.
- TENAX THERAPEUTICS, INC. amortization of debt discount (premium) for the quarter ending 2012-07-31 was $408.00K, a 200.00% increase year-over-year.
- TENAX THERAPEUTICS, INC. amortization of debt discount (premium) for the quarter ending 2012-01-31 was $408.00K.
- TENAX THERAPEUTICS, INC. amortization of debt discount (premium) for fiscal 2015 was $16.68K, a 96.55% decline from fiscal 2014.
- TENAX THERAPEUTICS, INC. amortization of debt discount (premium) for fiscal 2014 was $483.33K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2015-04-30 | $16.68K 10-K · filed 2017-03-16 | |||
| 2014-04-30 | $483.33K 10-K · filed 2017-03-16 | |||
| 2013-01-31 | $408.00K 10-Q · filed 2013-03-18 | $816.00K derived: sum of 2 quarters · filed 2013-03-18 | $1.23M 10-Q · filed 2013-03-18 | |
| 2012-10-31 | $408.00K 10-Q · filed 2012-12-14 | $816.00K 10-Q · filed 2012-12-14 | ||
| 2012-07-31 | $408.00K 10-Q · filed 2012-09-19 | |||
| 2012-01-31 | $408.00K 10-Q · filed 2013-03-18 | $816.00K derived: sum of 2 quarters · filed 2013-03-18 | $1.23M 10-Q · filed 2013-03-18 | |
| 2011-10-31 | $408.00K 10-Q · filed 2012-12-14 | $816.00K 10-Q · filed 2012-12-14 | ||
| 2011-07-31 | $136.00K 10-Q · filed 2012-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |